Corona Remedies IPO

Corona Remedies IPO is a book-built issue worth Rs 655.37 crores, consisting entirely of an Offer for Sale of 0.62 crore shares. The IPO will open for subscription on December 8, 2025, and close on December 10, 2025, with allotment expected on December 11, 2025, and listing on BSE and NSE scheduled for December 15, 2025. The price band is set at Rs 1,008–1,062 per share, and the lot size is 14 shares, requiring a minimum retail investment of Rs 14,868. The sNII investment stands at Rs 2,08,152, while bNII requires Rs 10,11,024. JM Financial Ltd. is the lead manager.

Open Demat Account

Corona Remedies IPO Details

Check out the issue details for Corona Remedies IPO as disclosed in SEBI.

IPO Price

₹ 1062

Price Band

₹ 1008 - 1062

Issue Size

655.37 Cr.

Issue Type

Book Built

Open

2025-12-08

Close

2025-12-10

Listing price

₹ 1470

Listing Gain

38.42%

Listing Date

2025-12-15

CMP

₹ 1893.3

Current Return

78.28%

Company Financials

You can get the following financial statements of Corona Remedies as of now.

Corona Remedies IPO Details

The details about the Corona Remedies IPO are as follows:

  • The issue size of the IPO is Rs 655.37 Cr.
  • The price band for Corona Remedies IPO is Rs 1008 to Rs 1062..
  • The shares of Corona Remedies IPO will list on BSE and NSE.
  • The latest tentative GMP of Corona Remedies IPO is Rs 310.
  • The shares of Corona Remedies IPO are subscribed 144.50 Times.

 

Corona Remedies IPO Valuation

The approximate valuation of Corona Remedies IPO based on its price band and RHP is:

Particulars Value
Upper Price Band Rs 1062
Existing Shares (Qty) 6.11 Cr
Market Cap Rs 6488.82 Cr
EPS (FY25) Rs 24.43
PE Ratio 43.47x
Industry PE 43.74x

 

Corona Remedies IPO Issue Size

Corona Remedies IPO issue size is Rs 655.37 Cr.

Issue Amount
Fresh Issue Rs 0 Cr
Offer For Sale Rs 655.37 Cr

 

Corona Remedies IPO Market Lot

An individual can apply for a minimum of 1 lot of 14 shares and a maximum of 13 lots (182 shares). Find the details below:

Application Lot Shares Amount
Retail Minimum 1 14 Rs 14,868
Retail Maximum 13 182 Rs 1,93,284

 

Corona Remedies IPO Share Offer

The shares of Corona Remedies IPO are subscribed 144.50 Times. The category-wise shares offered are as follows:

Category % Offered
Qualified Institutional Not more than 50%
Non-Institutional Not less than 15%
Retail Individual Not less than 35%

 

Corona Remedies IPO GMP (Grey Market Premium)

As on GMP (Tentative)
10 December 2025 Rs 310

Corona Remedies IPO GMP is purely for informational purposes. Invest in an IPO after thoroughly researching on your own.

Corona Remedies IPO Dates

Find below the dates for Corona Remedies IPO

Schedule Date
Basis of Allotment 11 Dec 2025
Refunds 12 Dec 2025
Credit to Demat Account 12 Dec 2025
IPO Listing Date 15 Dec 2025

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 617.33 884.05 1014.47 1196.42 1403.18
Total Expenditure 599.51 756.07 859.74 956.44 1109.74
Operating Profit 17.82 127.98 154.74 239.98 293.44
Other Income 6.6 7.05 6.46 5.93 10.65
Interest 4.73 4.27 14.44 10.6 6.97
Depreciation 20.48 20.1 28.28 37.16 37.87
Exceptional Items 0 0 0 0 -19.1
Profit Before Tax -0.8 110.66 118.48 198.15 240.15
Provision for Tax -0.4 25.96 27.98 49.1 55.3
Net Profit -0.4 84.7 90.5 149.05 184.85
Adjusted EPS (Rs.) -0.03 1.38 1.48 2.44 3.02

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 51.05 61.55 61.16 61.16 61.16
Total Reserves 269.86 346.75 419.02 544.56 684.81
Borrowings 16.54 0 67 16 0
Other N/C liabilities 22.29 44.88 58.98 67.93 97.11
Current liabilities 193.92 209.26 268.81 327.1 454.53
Total Liabilities 553.65 662.43 874.96 1016.75 1297.61
Assets
Net Block 161.76 184.6 383.7 369.88 553.97
Capital WIP 14.23 64.71 120.59 185.95 143.12
Intangible WIP 0 0 0 0 0
Investments 7.07 25.3 25.31 25.34 25.4
Loans & Advances 4.21 9.54 8.56 9.1 4.75
Other N/C Assets 36.71 14.91 2.26 0.1 128.7
Current Assets 329.68 363.38 334.54 426.38 441.67
Total Assets 553.65 662.43 874.96 1016.75 1297.61
* Other Non-current Liabilities include Net deferred Liabilities

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2025 Dec 2025 Mar 2026
Other Income 2.27 2.24 4.11
Profit Before Tax 69.61 55.19 54.46
Tax 17.46 13.94 9.41
Profit After Tax 52.15 41.25 45.05
Adjusted EPS (Rs) 8.53 6.74 7.37

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2026 69 0
Dec 2025 69 0
* Figures given above are % of equity capital

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations -0.8 110.66 118.48 198.15 240.15
Adjustment 20.34 22.78 46.87 52.69 44.62
Changes in Assets & Liabilities 79.66 -4.91 9.32 -17.07 -5.87
Tax Paid -1.5 -25.82 -17.91 -43.28 -49.42
Operating Cash Flow 97.71 102.7 156.76 190.49 229.48
Investing Cash Flow -65.81 -50.28 -266.64 -83.86 -256.15
Financing Cash Flow -29.86 -44.75 98.54 -106.57 25.28
Net Cash Flow 2.04 7.67 -11.34 0.06 -1.39
X